Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71001 - 71025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	HOGA1	112817	downregulated	Silicon Dioxide analog results in decreased expression of HOGA1 mRNA	10q24.2	A24195
Silicon dioxide	Approved	HOMER1	9456	upregulated	Silicon Dioxide analog results in increased expression of HOMER1 mRNA	5q14.1	A24194
Silicon dioxide	Approved	HOMER3	9454	upregulated	Silicon Dioxide analog results in increased expression of HOMER3 mRNA	19p13.11	A24194 A24195
Silicon dioxide	Approved	HOOK1	51361	downregulated	Silicon Dioxide analog results in decreased expression of HOOK1 mRNA	1p32.1	A24195
Silicon dioxide	Approved	HOXA13	3209	downregulated	Silicon Dioxide analog results in decreased expression of HOXA13 mRNA	7p15.2	A24194
Silicon dioxide	Approved	HOXA2	3199	upregulated	Silicon Dioxide analog results in increased expression of HOXA2 mRNA	7p15.2	A24195
Silicon dioxide	Approved	HOXA9	3205	upregulated	Silicon Dioxide analog results in increased expression of HOXA9 mRNA	7p15.2	A24194
Silicon dioxide	Approved	HOXB13	10481	downregulated	Silicon Dioxide analog results in decreased expression of HOXB13 mRNA	17q21.32	A24195
Silicon dioxide	Approved	HOXB2	3212	downregulated	Silicon Dioxide analog results in decreased expression of HOXB2 mRNA	17q21.32	A24195
Silicon dioxide	Approved	HOXB5	3215	downregulated	Silicon Dioxide analog results in decreased expression of HOXB5 mRNA	17q21.32	A24195
Silicon dioxide	Approved	HOXB6	3216	downregulated	Silicon Dioxide analog results in decreased expression of HOXB6 mRNA	17q21.32	A24195
Silicon dioxide	Approved	HOXD1	3231	downregulated	Silicon Dioxide analog results in decreased expression of HOXD1 mRNA	2q31.1	A24195
Silicon dioxide	Approved	HOXD1	3231	upregulated	Silicon Dioxide analog results in increased expression of HOXD1 mRNA	2q31.1	A24194
Silicon dioxide	Approved	HOXD3	3232	upregulated	Silicon Dioxide analog results in increased expression of HOXD3 mRNA	2q31.1	A24194
Silicon dioxide	Approved	HOXD8	3234	downregulated	Silicon Dioxide analog results in decreased expression of HOXD8 mRNA	2q31.1	A24195
Silicon dioxide	Approved	HP	3240	downregulated	Silicon Dioxide analog results in decreased expression of HP mRNA	16q22.2	A24195
Silicon dioxide	Approved	HP	3240	upregulated	Silicon Dioxide analog results in increased expression of HP mRNA	16q22.2	A24194
Silicon dioxide	Approved	HPD	3242	downregulated	Silicon Dioxide analog results in decreased expression of HPD mRNA	12q24.31	A24195
Silicon dioxide	Approved	HPDL	84842	upregulated	Silicon Dioxide analog results in increased expression of HPDL mRNA	1p34.1	A24195
Silicon dioxide	Approved	HPGD	3248	downregulated	Silicon Dioxide results in decreased expression of HPGD mRNA	4q34.1	A24196
Silicon dioxide	Approved	HPX	3263	downregulated	Silicon Dioxide analog results in decreased expression of HPX mRNA	11p15.4	A24195
Silicon dioxide	Approved	HRAS	3265	upregulated	Silicon Dioxide analog results in increased expression of HRAS mRNA	11p15.5	A24195
Silicon dioxide	Approved	HRASLS	57110	upregulated	Silicon Dioxide analog results in increased expression of HRASLS mRNA	3q29	A24194
Silicon dioxide	Approved	HRASLS2	54979	downregulated	Silicon Dioxide results in decreased expression of HRASLS2 mRNA	11q12.3	A24196
Silicon dioxide	Approved	HRASLS5	117245	upregulated	Silicon Dioxide analog results in increased expression of HRASLS5 mRNA	11q12.3	A24195

Displaying entries 71001 - 71025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability